The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Brief Title: Randomized Study Of CP-675,206 or Best Supportive Care Immediately After Platinum-Based Therapy For Non-Small Cell Lung Cancer (NSCLC)
Official Title: Phase 2 Randomized, Non-Comparative Study Of CP-675,206 Or Best Supportive Care Immediately Following First-Line, Platinum-Based Therapy In Patients With Stage IIIB (With Effusion) Or Stage IV Non-Small Cell Lung Cancer That Has Responded Or Remained Stable
Study ID: NCT00312975
Brief Summary: The purpose of this trial is to study how long patients can remain progression free when they receive CP-675,206, compared to how long patients can remain progression free when they receive best supportive care. If you choose to take part, you will be randomized to receive either CP-675,206 as maintenance therapy or best supportive care. Best supportive care means you will not receive any study drug or other treatment for your cancer. Best supportive care could include treatment with antibiotics, analgesic drugs (medicine for pain), blood transfusions or psychosocial and nutritional support, depending on your needs. You have a 50% chance of being randomized to receive CP-675,206.
Detailed Description:
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Research Site, Bentonville, Arkansas, United States
Research Site, Fayetteville, Arkansas, United States
Research Site, Orange, California, United States
Research Site, Danbury, Connecticut, United States
Research Site, Atlanta, Georgia, United States
Research Site, Lexington, Kentucky, United States
Research Site, Alexandria, Louisiana, United States
Research Site, New York, New York, United States
Research Site, Oneida, New York, United States
Research Site, Oswego, New York, United States
Research Site, Syracuse, New York, United States
Research Site, Syracuse, New York, United States
Research Site, Canton, Ohio, United States
Research Site, Philadelphia, Pennsylvania, United States
Research Site, Calgary, Alberta, Canada
Research Site, Calgary, Alberta, Canada
Research Site, Edmonton, Alberta, Canada
Research Site, Montreal, Quebec, Canada
Research Site, Praha 8, , Czech Republic
Research Site, Tabor, , Czech Republic
Research Site, Usti nad Labem, , Czech Republic
Research Site, Seoul, , Korea, Republic of
Research Site, Seoul, , Korea, Republic of
Research Site, Seoul, , Korea, Republic of
Research Site, Southampton, Hampshire, United Kingdom
Research Site, London, , United Kingdom